Dr. Moyo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1021 Morehead Medical Dr.
Bldg II, Suite 60100
Charlotte, NC 28204Phone+1 704-442-2000- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2017
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2010 - 2012
- University of North Carolina at Chapel Hill School of MedicineClass of 2010
Certifications & Licensure
- TN State Medical License 2017 - 2024
- NC State Medical License 2019 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy.Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Br...> ;Blood Advances. 2024 Mar 18
- Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis.Zhao, Q., Watkins, M., Reddy, N., Thomas, C., Shouse, G., Olszewski, A., Epperla, N., Moyo, T., Tavakkoli, M., Bello, C., Torka, P., Annunzio, K., Barta, S., Bartlett,...> ;Blood Advances. 2024 Feb 13
- Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia.Issam S Hamadeh, Jai N Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Ste...> ;Clinical Cancer Research. 2023 Dec 1
- Join now to see all
Abstracts/Posters
- Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation CohortTamara Moyo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart¬ Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) PatientsTamara Moyo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology AssociationJune 1st, 2018
- TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 58th American Society of Hematology Annual MeetingNovember 3rd, 2016
- Study Identifies New Culprit in Lung Cancer DevelopmentJanuary 27th, 2016
Hospital Affiliations
- Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: